[Corrections] Correction to Lancet Infect Dis 2022; published online Sept 13. https://doi.org/10.1016/S1473-3099(22)00318-8

Wedemeyer H, Schöneweis K, Bogomolov P, et al. Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial. Lancet Infect Dis 2022; published online Sept 13. https://doi.org/10.1016/S1473-3099(22)00318-8—In this Article, the four curves of figure 2, panel D, were mislabeled and have been rectified. These corrections have been made to the online version as of Oct 28, 2022, and the printed version is correct.

Comments (0)

No login
gif